SRPT logo

Sarepta Therapeutics, Inc. (SRPT) Gross Profit

Annual Gross Profit:

$1.55B+$496.56M(+47.35%)
December 31, 2024

Summary

  • As of today, SRPT annual gross profit is $1.55 billion, with the most recent change of +$496.56 million (+47.35%) on December 31, 2024.
  • During the last 3 years, SRPT annual gross profit has risen by +$978.34 million (+172.60%).
  • SRPT annual gross profit is now at all-time high.

Performance

SRPT Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

Quarterly Gross Profit:

$230.13M-$217.56M(-48.60%)
September 30, 2025

Summary

  • As of today, SRPT quarterly gross profit is $230.13 million, with the most recent change of -$217.56 million (-48.60%) on September 30, 2025.
  • Over the past year, SRPT quarterly gross profit has dropped by -$135.54 million (-37.07%).
  • SRPT quarterly gross profit is now -61.47% below its all-time high of $597.31 million, reached on March 31, 2025.

Performance

SRPT Quarterly Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

TTM Gross Profit:

$1.79B-$135.54M(-7.04%)
September 30, 2025

Summary

  • As of today, SRPT TTM gross profit is $1.79 billion, with the most recent change of -$135.54 million (-7.04%) on September 30, 2025.
  • Over the past year, SRPT TTM gross profit has increased by +$420.06 million (+30.64%).
  • SRPT TTM gross profit is now -7.04% below its all-time high of $1.93 billion, reached on June 30, 2025.

Performance

SRPT TTM Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

Gross Profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

SRPT Gross Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+47.4%-37.1%+30.6%
3Y3 Years+172.6%+28.1%+158.2%
5Y5 Years+377.8%+88.2%+327.7%

SRPT Gross Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+172.6%-61.5%+28.1%-7.0%+158.2%
5Y5-Yearat high+377.8%-61.5%+99.3%-7.0%+327.7%
All-TimeAll-Timeat high>+9999.0%-61.5%+2853.1%-7.0%+6918.4%

SRPT Gross Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
$230.13M(-48.6%)
$1.79B(-7.0%)
Jun 2025
-
$447.69M(-25.0%)
$1.93B(+7.7%)
Mar 2025
-
$597.31M(+15.8%)
$1.79B(+15.7%)
Dec 2024
$1.55B(+47.4%)
$515.65M(+41.0%)
$1.55B(+12.7%)
Sep 2024
-
$365.68M(+18.1%)
$1.37B(+6.3%)
Jun 2024
-
$309.67M(-12.6%)
$1.29B(+7.8%)
Mar 2024
-
$354.16M(+3.8%)
$1.20B(+14.0%)
Dec 2023
$1.05B(+39.6%)
$341.23M(+20.2%)
$1.05B(+13.4%)
Sep 2023
-
$283.86M(+31.2%)
$924.44M(+12.7%)
Jun 2023
-
$216.32M(+4.4%)
$820.19M(+3.9%)
Mar 2023
-
$207.18M(-4.6%)
$789.67M(+5.1%)
Dec 2022
$751.16M(+32.5%)
$217.07M(+20.9%)
$751.16M(+8.3%)
Sep 2022
-
$179.61M(-3.3%)
$693.66M(+3.6%)
Jun 2022
-
$185.80M(+10.2%)
$669.51M(+8.0%)
Mar 2022
-
$168.67M(+5.7%)
$619.83M(+9.4%)
Dec 2021
$566.82M(+26.0%)
$159.57M(+2.6%)
$566.82M(+8.4%)
Sep 2021
-
$155.47M(+14.2%)
$522.70M(+6.8%)
Jun 2021
-
$136.13M(+17.7%)
$489.52M(+3.9%)
Mar 2021
-
$115.66M(+0.2%)
$470.94M(+4.7%)
Dec 2020
$449.81M(+39.1%)
$115.45M(-5.6%)
$449.81M(+7.4%)
Sep 2020
-
$122.29M(+4.0%)
$418.71M(+9.6%)
Jun 2020
-
$117.55M(+24.4%)
$382.20M(+11.4%)
Mar 2020
-
$94.52M(+12.1%)
$343.19M(+6.1%)
Dec 2019
$323.40M(+21.6%)
$84.35M(-1.7%)
$323.40M(+4.3%)
Sep 2019
-
$85.79M(+9.2%)
$310.12M(+5.5%)
Jun 2019
-
$78.53M(+5.1%)
$293.86M(+4.2%)
Mar 2019
-
$74.73M(+5.2%)
$281.90M(+6.0%)
Dec 2018
$265.98M(+82.0%)
$71.06M(+2.2%)
$265.98M(+7.1%)
Sep 2018
-
$69.53M(+4.4%)
$248.43M(+12.4%)
Jun 2018
-
$66.58M(+13.2%)
$220.99M(+18.1%)
Mar 2018
-
$58.81M(+9.9%)
$187.15M(+31.1%)
Dec 2017
$146.18M(>+9900.0%)
$53.52M(+27.1%)
$142.80M(+53.7%)
Sep 2017
-
$42.10M(+28.6%)
$92.91M(+86.8%)
Jun 2017
-
$32.73M(+126.5%)
$49.74M(+220.3%)
Mar 2017
-
$14.45M(+298.5%)
$15.53M(+4953.1%)
Dec 2016
-$320.00K(>-9900.0%)
$3.63M(+437.7%)
-$320.00K(+91.9%)
Sep 2016
-
-$1.07M(+27.2%)
-$3.95M(+5.7%)
Jun 2016
-
-$1.48M(-5.7%)
-$4.18M(-4.6%)
Mar 2016
-
-$1.40M(>-9900.0%)
-$4.00M(-3.0%)
Dec 2015
$0.00(0.0%)
$0.00(+100.0%)
-$3.88M(0.0%)
Sep 2015
-
-$1.31M(-1.6%)
-$3.88M(-51.0%)
Jun 2015
-
-$1.29M(-0.9%)
-$2.57M(-100.9%)
Mar 2015
-
-$1.28M(>-9900.0%)
-$1.28M(>-9900.0%)
Dec 2014
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2014
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2014
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2014
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2013
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2013
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
$0.00(+100.0%)
Mar 2013
-
$0.00(0.0%)
-$2.64M(0.0%)
Dec 2012
$0.00(-100.0%)
$0.00(0.0%)
-$2.64M(+63.4%)
Sep 2012
-
$0.00(+100.0%)
-$7.21M(+53.7%)
Jun 2012
-
-$2.64M(>-9900.0%)
-$15.57M(+19.5%)
Mar 2012
-
$0.00(+100.0%)
-$19.34M(+3.7%)
Dec 2011
$45.69M
-$4.57M(+45.4%)
-$20.09M(-29.4%)
Sep 2011
-
-$8.36M(-30.3%)
-$15.52M(-1407.4%)
DateAnnualQuarterlyTTM
Jun 2011
-
-$6.42M(-762.4%)
$1.19M(-89.4%)
Mar 2011
-
-$744.00K(>-9900.0%)
$11.25M(-12.5%)
Dec 2010
$0.00(0.0%)
$0.00(-100.0%)
$12.85M(0.0%)
Sep 2010
-
$8.35M(+128.9%)
$12.85M(+185.3%)
Jun 2010
-
$3.65M(+324.9%)
$4.50M(+424.9%)
Mar 2010
-
$858.00K(>+9900.0%)
$858.00K(>+9900.0%)
Dec 2009
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2009
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2009
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2009
-
$0.00(0.0%)
$0.00(+100.0%)
Dec 2008
$0.00(0.0%)
$0.00(0.0%)
-$1.85M(0.0%)
Sep 2008
-
$0.00(0.0%)
-$1.85M(+79.0%)
Jun 2008
-
$0.00(+100.0%)
-$8.82M(+43.6%)
Mar 2008
-
-$1.85M(>-9900.0%)
-$15.63M(+20.1%)
Dec 2007
$0.00(0.0%)
$0.00(+100.0%)
-$19.56M(+25.5%)
Sep 2007
-
-$6.97M(-2.3%)
-$26.26M(-4.1%)
Jun 2007
-
-$6.81M(-17.8%)
-$25.22M(-3.7%)
Mar 2007
-
-$5.78M(+13.8%)
-$24.31M(+3.6%)
Dec 2006
$0.00(0.0%)
-$6.70M(-13.1%)
-$25.23M(-14.6%)
Sep 2006
-
-$5.93M(-0.4%)
-$22.02M(-29.8%)
Jun 2006
-
-$5.90M(+11.9%)
-$16.96M(-13.6%)
Mar 2006
-
-$6.70M(-91.6%)
-$14.93M(-81.3%)
Dec 2005
$0.00(0.0%)
-$3.50M(-304.0%)
-$8.24M(-73.7%)
Sep 2005
-
-$865.40K(+77.7%)
-$4.74M(+41.0%)
Jun 2005
-
-$3.88M(>-9900.0%)
-$8.03M(+21.8%)
Mar 2005
-
$0.00(0.0%)
-$10.27M(0.0%)
Dec 2004
$0.00(0.0%)
$0.00(+100.0%)
-$10.27M(+3.0%)
Sep 2004
-
-$4.16M(+32.0%)
-$10.59M(-10.9%)
Jun 2004
-
-$6.12M(>-9900.0%)
-$9.56M(-64.3%)
Mar 2004
-
$0.00(+100.0%)
-$5.82M(+30.5%)
Dec 2003
$0.00(0.0%)
-$321.00K(+89.7%)
-$8.37M(-4.0%)
Sep 2003
-
-$3.12M(-31.2%)
-$8.04M(+13.4%)
Jun 2003
-
-$2.38M(+6.7%)
-$9.29M(+33.4%)
Mar 2003
-
-$2.55M(>-9900.0%)
-$13.94M(+23.4%)
Dec 2002
$0.00(0.0%)
$0.00(+100.0%)
-$18.20M(0.0%)
Sep 2002
-
-$4.36M(+37.9%)
-$18.20M(-11.6%)
Jun 2002
-
-$7.03M(-3.2%)
-$16.30M(-32.0%)
Mar 2002
-
-$6.81M(>-9900.0%)
-$12.35M(-52.2%)
Dec 2001
$0.00(0.0%)
$0.00(+100.0%)
-$8.12M(0.0%)
Sep 2001
-
-$2.47M(+19.8%)
-$8.12M(-5.6%)
Jun 2001
-
-$3.08M(-19.4%)
-$7.69M(-8.6%)
Mar 2001
-
-$2.58M(>-9900.0%)
-$7.08M(-33.4%)
Dec 2000
$0.00(+100.0%)
$0.00(+100.0%)
-$5.30M(+27.0%)
Sep 2000
-
-$2.03M(+17.5%)
-$7.27M(-3.1%)
Jun 2000
-
-$2.47M(-206.5%)
-$7.05M(-13.5%)
Mar 2000
-
-$804.60K(+59.0%)
-$6.21M(+8.7%)
Dec 1999
-$6.73M(-8.7%)
-$1.96M(-8.2%)
-$6.81M(-40.5%)
Sep 1999
-
-$1.82M(-11.4%)
-$4.84M(-5.9%)
Jun 1999
-
-$1.63M(-16.5%)
-$4.57M(-7.8%)
Mar 1999
-
-$1.40M(>-9900.0%)
-$4.24M(-2.7%)
Dec 1998
-$6.19M(-127.2%)
$0.00(+100.0%)
-$4.13M(-5.1%)
Sep 1998
-
-$1.54M(-19.0%)
-$3.93M(-64.7%)
Jun 1998
-
-$1.30M(-0.7%)
-$2.39M(-202.6%)
Mar 1998
-
-$1.29M(-744.3%)
-$788.60K(-212.7%)
Dec 1997
-$2.72M(-553.8%)
$200.00K(-33.3%)
$700.00K(+40.0%)
Jun 1997
-
$300.00K(+50.0%)
$500.00K(+150.0%)
Mar 1997
-
$200.00K
$200.00K
Dec 1996
$600.00K
-
-

FAQ

  • What is Sarepta Therapeutics, Inc. annual gross profit?
  • What is the all-time high annual gross profit for Sarepta Therapeutics, Inc.?
  • What is Sarepta Therapeutics, Inc. annual gross profit year-on-year change?
  • What is Sarepta Therapeutics, Inc. quarterly gross profit?
  • What is the all-time high quarterly gross profit for Sarepta Therapeutics, Inc.?
  • What is Sarepta Therapeutics, Inc. quarterly gross profit year-on-year change?
  • What is Sarepta Therapeutics, Inc. TTM gross profit?
  • What is the all-time high TTM gross profit for Sarepta Therapeutics, Inc.?
  • What is Sarepta Therapeutics, Inc. TTM gross profit year-on-year change?

What is Sarepta Therapeutics, Inc. annual gross profit?

The current annual gross profit of SRPT is $1.55B

What is the all-time high annual gross profit for Sarepta Therapeutics, Inc.?

Sarepta Therapeutics, Inc. all-time high annual gross profit is $1.55B

What is Sarepta Therapeutics, Inc. annual gross profit year-on-year change?

Over the past year, SRPT annual gross profit has changed by +$496.56M (+47.35%)

What is Sarepta Therapeutics, Inc. quarterly gross profit?

The current quarterly gross profit of SRPT is $230.13M

What is the all-time high quarterly gross profit for Sarepta Therapeutics, Inc.?

Sarepta Therapeutics, Inc. all-time high quarterly gross profit is $597.31M

What is Sarepta Therapeutics, Inc. quarterly gross profit year-on-year change?

Over the past year, SRPT quarterly gross profit has changed by -$135.54M (-37.07%)

What is Sarepta Therapeutics, Inc. TTM gross profit?

The current TTM gross profit of SRPT is $1.79B

What is the all-time high TTM gross profit for Sarepta Therapeutics, Inc.?

Sarepta Therapeutics, Inc. all-time high TTM gross profit is $1.93B

What is Sarepta Therapeutics, Inc. TTM gross profit year-on-year change?

Over the past year, SRPT TTM gross profit has changed by +$420.06M (+30.64%)
On this page